Specific activation of the alpha 7 nicotinic acetylcholine receptor by a quaternary analog of cocaine.

Effects of cocaine and cocaine methiodide were evaluated on the homomeric alpha 7 neuronal nicotinic receptor (nAChR). Whereas cocaine itself is a general nAChR noncompetitive antagonist, we report here the characterization of cocaine methiodide, a novel selective agonist for the alpha 7 subtype of nAChR. Data from (125)I-alpha-bungarotoxin binding assays indicate that cocaine methiodide binds to alpha 7 nAChR with a K(i) value of approximately 200 nM while electrophysiology studies indicate that the addition of a methyl group at the amine moiety of cocaine changes the drug's activity profile from inhibitor to agonist. Cocaine methiodide activates alpha 7 nAChR with an EC(50) value of approximately 50 microM and shows comparable efficacy to ACh in oocyte experiments. While agonist effects are specific for the alpha 7 neuronal nAChR and are not observed with heteromeric neuronal or skeletal muscle nAChR, antagonist effects are present for heteromeric nAChR combinations. Studies of PC12 cells transiently transfected with human alpha 7 cDNA and expressing a variety of functional nicotinic receptor subtypes confirm the specificity of cocaine methiodide agonist effects. Our results indicate that a quaternary structural derivative of cocaine can be used as a specific agonist for the alpha 7 subtype of neuronal nicotinic receptor.

[1]  J. Macor,et al.  (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. , 2000, Journal of medicinal chemistry.

[2]  A. Fox,et al.  Neuronal α-Bungarotoxin Receptors Differ Structurally from Other Nicotinic Acetylcholine Receptors , 1997, The Journal of Neuroscience.

[3]  R. Oswald,et al.  Identification of a new amino acid residue capable of modulating agonist efficacy at the homomeric nicotinic acetylcholine receptor, alpha7. , 1999, Molecular pharmacology.

[4]  R Freedman,et al.  Nicotinic receptor function in schizophrenia. , 1996, Schizophrenia bulletin.

[5]  E. Albuquerque,et al.  Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. , 1993, The Journal of pharmacology and experimental therapeutics.

[6]  E. Albuquerque,et al.  Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. , 1986, Molecular pharmacology.

[7]  R. Lukas,et al.  Similarity Between Rat Brain Nicotinic α‐Bungarotoxin Receptors and Stably Expressed α‐Bungarotoxin Binding Sites , 1996 .

[8]  M. Quik,et al.  Nicotinic receptors and Parkinson's disease. , 2000, European journal of pharmacology.

[9]  D. Bertrand,et al.  Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor. , 1995, European journal of pharmacology.

[10]  R. Papke,et al.  Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. , 1998, The Journal of pharmacology and experimental therapeutics.

[11]  William R Kem,et al.  The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21) , 2000, Behavioural Brain Research.

[12]  J. Udgaonkar,et al.  Chemical kinetic measurements of a mammalian acetylcholine receptor by a fast-reaction technique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Papke,et al.  Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes. , 1995, Molecular pharmacology.

[14]  D. K. Berg,et al.  Detection of Functional Nicotinic Receptors Blocked by α-Bungarotoxin on PC12 Cells and Dependence of Their Expression on Post-Translational Events , 1997, The Journal of Neuroscience.

[15]  R. Maue,et al.  Nerve growth factor increases nicotinic ACh receptor gene expression and current density in wild-type and protein kinase A-deficient PC12 cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  W. Sweileh,et al.  Multistep expression and assembly of neuronal nicotinic receptors is both host-cell- and receptor-subtype-dependent. , 2000, Brain research. Molecular brain research.

[17]  J. Sullivan,et al.  Activation of the recombinant human alpha 7 nicotinic acetylcholine receptor significantly raises intracellular free calcium. , 1997, The Journal of pharmacology and experimental therapeutics.

[18]  D. Clifford,et al.  Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons. , 1992, Molecular pharmacology.

[19]  E. Neher,et al.  Local anaesthetics transiently block currents through single acetylcholine‐receptor channels. , 1978, The Journal of physiology.

[20]  J. Patrick,et al.  Amino Acid Determinants of α7 Nicotinic Acetylcholine Receptor Surface Expression* , 2000, The Journal of Biological Chemistry.

[21]  D. Sagher,et al.  α-Bungarotoxin Receptors Contain α7 Subunits in Two Different Disulfide-Bonded Conformations , 1999, The Journal of cell biology.

[22]  J. Daly,et al.  Epibatidine, a potent analgetic and nicotinic agonist. , 1994, Molecular pharmacology.

[23]  R. Lukas,et al.  Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites. , 1996, Journal of neurochemistry.

[24]  P. De Koninck,et al.  Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic ACh receptor subunits. , 1995, Journal of neurophysiology.

[25]  R. Papke,et al.  An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype , 1996, Neuroscience Letters.

[26]  W. N. Green,et al.  Neuronal α-Bungarotoxin Receptors Are α7 Subunit Homomers , 2000, The Journal of Neuroscience.

[27]  D. Bertrand,et al.  Functional expression of nicotinic acetylcholine receptors containing rat α7 subunits in human SH‐SY5Y neuroblastoma cells , 1994, FEBS letters.

[28]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[29]  Zhong-Wei Zhang,et al.  Neuronal acetylcholine receptors that bind α-bungarotoxin with high affinity function as ligand-gated ion channels , 1994, Neuron.

[30]  S. Heinemann,et al.  The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  T. Lewis,et al.  The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type , 1997, The Journal of physiology.

[32]  R. Papke,et al.  The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes , 1998, Neuroscience Letters.

[33]  D. Bertrand,et al.  Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. , 1996, The Journal of physiology.

[34]  J. B. Pitner,et al.  N-modified analogues of cocaine: synthesis and inhibition of binding to the cocaine receptor. , 1992, Journal of medicinal chemistry.

[35]  W. N. Green,et al.  Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  R. Papke,et al.  Subtype-Selective Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Cocaine Is Determined by the α4 and β4 Subunits , 2000 .

[37]  N. Millar,et al.  Host Cell‐Specific Folding and Assembly of the Neuronal Nicotinic Acetylcholine Receptor α7 Subunit , 1997, Journal of neurochemistry.